Public offering

Vigil Neuroscience announces the price of its initial public offering | Your money

CAMBRIDGE, Mass., Jan.6, 2022 (GLOBE NEWSWIRE) – Vigil Neuroscience, Inc. (Nasdaq: VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, announced today hui the price of its initial public offering of 7,000,000 common shares at a public price of $ 14.00 …

Read More »

Ares Capital Corporation Offers $ 500 Million Public Offering of 2.875% Unsecured Bonds Due 2027

NEW YORK–(COMMERCIAL THREAD) – Ares Capital Corporation (Nasdaq: ARCC) has announced that it has priced a $ 500 million subscribed public offering with a total principal amount of 2.875% of bonds maturing in 2027. The bonds will expire on June 15, 2027 and may be redeemed in whole or in …

Read More »

Soluna Holdings, Inc.Announces Closing of Public Offering of $ 1.17 Million of Series A Preferred Shares Resulting from Full Exercise of the Over-Allotment Option

ALBANY, NY, Jan.5, 2022 (GLOBE NEWSWIRE) – via NewMediaWire – Soluna Holdings, Inc. (“SHI” or the “Company”), (NASDAQ: SLNH), the parent company of Soluna Computing, Inc. (“SCI”), a cryptocurrency mining company powered by Renewable Energy, and MTI Instruments, Inc. (“MTI Instruments”), an instrumentation and test and measurement systems company, today …

Read More »

Prices of intracellular therapies Public offering of ordinary shares – January 05, 2022

NEW YORK, January 04, 2022 (GLOBE NEWSWIRE) – Intracellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of treatments for central nervous system (CNS) disorders, today announced the price of its previously announced subscribed public offering of 9,523,810 common shares at a public offering price …

Read More »

Plantable Health completes its initial public offering

Vancouver, British Columbia – (Newsfile Corp. – December 31, 2021) – Plantable Health Inc. (“Plantable“or the”Society“), today announced the successful closing of its IPO (the”Offer“) Plantable units (“Units“) for C $ 0.40 (the”Offer price“) per Unit for gross proceeds of C $ 4.5 million. Clarus Securities Inc. (the”Agent“) acted as …

Read More »

Applied UV Announces Closing of $ 8.0 Million Public Offering

MOUNT VERNON, NY / ACCESSWIRE / December 31, 2021 / Applied UV, Inc. (NASDAQ: AUVI) (NASDAQ: AUVIP) (“Applied UV” or the “Company”), an industry leader in airborne pathogen removal technology and Surface, today announced the closing of its previously announced subscribed public offering of 2,666,667 common shares (the “Common Shares”) …

Read More »

Mayo Lake Receives Approval For Its Initial Public Offering | 2021-12-30 | Press Releases

Ottawa, Ontario – (Newsfile Corp. – December 30, 2021) – Mayo Lake Minerals Inc. (‘Mayo Lake‘or the’Society‘) is pleased to announce that it has completed its initial public offering (the “Offer“) under a prospectus dated December 15, 2021 (the”Prospectus“). In connection with the offering, the Company issued a total of …

Read More »

Nation Gold completes its IPO and CSE listing

Enter Wall Street with Street Insider Premium. Claim your 1-week free trial here. Vancouver, British Columbia – (Newsfile Corp. – December 30, 2021) – Nation Gold Corp. (CSE: NATN) (the “Society” Where “Nation“) is pleased to announce that following its press release dated December 22, 2021, it has completed its …

Read More »

Chinese professor buys $ 3.4 billion fortune with SenseTime initial public offering

A few weeks later, the United States blacklisted a unit of SenseTime Group Inc. for alleged human rights violations, the company will blacklist the perpetrator Tang Xiao ‘or one of the people. most extravagant in the world. China’s largest artificial intelligence organization estimated its initial public offering at HK $ …

Read More »

BiondVax announces a proposed public offer to subscribe for shares of a US custodian

JERUSALEM, 23 December 2021 / PRNewswire / – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biopharmaceutical company focused on the development, manufacture and commercialization of innovative products for the prevention and treatment of infectious diseases and other diseases, today announced its intention to offer its U.S. depository shares (“ADS”) as part …

Read More »